Hemoactiv

Hemoactiv

Name: Hemoactiv

International unlicensed name: Тranexamic acid 

Formulation: 500 mg, 100 mg/ml, 5 ampoules with 5 ml 

Composition: 1ml of solution for injection contains tranexamic acid 100mg

Exipients: water for injection

Pharmacotherapeutic group: Antihemorrhagic remedies. Inhibitors of fibrinolysis

Shelf life: 2 years

Certificate of registry number: № UA/16420/01/01 от 17.11.2017.

Certificate validity period: from 17.11.2017 to 17.11.2022 

The Ministry of Health of Ukraine Order № 1470 від 21.11.2017

AO code: B02A A02

Pharmacy sales category: By recipe

Manufacturer

PT. NOVELL PHARMACEUTICAL LABORATORIES


Application:

Bleeding or risk of hemorrhage with increased fibrinolysis, both generalized and local, in adults and children from 1 year of age.

Specific indications include:

  • Bleeding caused by elevated total or local fibrinolysis, such as:
  • Menorage and metrology;
  • Gastrointestinal bleeding;
  • Hemorrhagic disorders urinary tract, arising from surgical intervention in the prostate gland or as a result of surgical intervention or procedures on the urinary tract; - Otolaryngologic (removal of adenoids, tonsillectomy) and dental (tooth extraction) surgical interventions;
  • Gynecological operations or complications in obstetric practice;
  • Thoracic, abdominal and other major surgical interventions, such as cardiovascular surgery;
  • Control of hemorrhages due to the introduction of a fibrinolytic drug.